Category: Biotechnology

Shares of the Oncolytics Biotech are up by 8.1 percent

Oncolytics Biotech, Inc. (TSE:ONC’s) stock value shot up 8.1% during noontime exchanging on Friday . The organization exchanged as high as C$0.86 and last exchanged at C$0.80, 140,240 offers exchanged hands during exchanging an expansion of 289 percent from the normal session volume of 36,041 offers. The stock had recently shut at C$0.74.Independently, Royal Bank

Federal Trade Commission issued civil subpoenas to J&J as part of an investigation whether its blockbuster drug violated antitrust laws

Civil subpoenas were issued by FTC to J&J in June as part of scrutiny into whether contracting practices for its bestseller rheumatoid arthritis drug, Remicade, violated antitrust laws, the firm stated in a regulatory filing on Monday. Firm’s shares traded slightly down at $132.47, after having closed up 1.7 percent on Monday. According to Johnson

N.L. biotech looking for family doctors and 2500 people to volunteer their genetic & medical info for research

A Newfoundland & Labrador biotech firm is looking for 2,500 people to volunteer their genetic & medical information for research which seeks to develop novel treatments for common illnesses. The Chief Executive Officer of Sequence Bio, Chris Gardner stated that we are in the search for drug targets. Meaning, if we can identify particular changes

Gilead Sciences Inc. achieved to score a ‘Perfect 10’, weighed by the Smart Score metric

Most investors turn to biotechs when they’re in search of compelling stocks with momentous strategic growth potential. Any firm which employs technology that involves living organisms for creating agricultural or medical products is known as biotech. The S&P Biotech Select Industry Index gained 18 percent over the last decade. Several financial bloggers and analysts believe

University of Technology & PharmaCyte Biotech collaborated to create Advanced Version of Melligen Cells to Treat Diabetes

A clinical-stage biotech firm which is devoted to the development of targeted treatments for cancer & diabetes using its signature live-cell encapsulation technology known as cell-in-a-box, PharmaCyte Biotech, Inc., made an announcement today that has tapped into a new research agreement with the Australia’s University of Technology Sydney to develop a new version of Melligen

Swiss Biotechnology firm gets a patent for the Canadian bio markets

Swiss biotech firm NLS Pharmaceutics Ltd, which spotlights on the improvement of novel medicines for the focal sensory system (CNS)— specifically consideration shortage hyperactivity issue (ADHD) just as hypersomnia (counting narcolepsy, idiopathic hypersomnia, and Kleine Levin disorder)— and other neurological maladies, has gotten a notice of recompense for a patent from the Canadian Intellectual Property

Biotech Growing In KSA and UAE

Saudi Arabia was focusing lately on the growth of their pharmaceutical market to help shift their economy. The government has focused on investing and building plants in all directions to help reach this vision. Accordingly, news show that there has been a huge increase in the marketplace for pharamceuticals and biotech in the Kingdom of